Orphan Drug Act
United States [1983]
Quick Summary
The Orphan Drug Act of 1983 was enacted in the United States to encourage the development of drugs for rare diseases. These drugs, often called "orphan drugs," are typically not profitable for pharmaceutical companies to develop or market due to their extremely limited patient populations. The act provides incentives to stimulate research and development for these conditions, ensuring that patients with rare diseases have access to potential treatments.12
Summary created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
2 Britannica Sources
Ask Britannica AI about this topic
Britannica doesn't have a full article on this topic, so we've curated a list of our relevant coverage.
